Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.

Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB.

Int J Antimicrob Agents. 2019 Oct 30. pii: S0924-8579(19)30294-8. doi: 10.1016/j.ijantimicag.2019.10.014. [Epub ahead of print] Review.

PMID:
31730892
2.

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.

Rao GG, Konicki R, Cattaneo D, Alffenaar JW, Marriott DJ, Neely M.

Ther Drug Monit. 2019 Oct 23. doi: 10.1097/FTD.0000000000000710. [Epub ahead of print]

PMID:
31652190
3.

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment.

Reader J, Harper AK, Legesse T, Staats PN, Goloubeva O, Rao GG, Fulton A, Roque DM.

Cancers (Basel). 2019 Oct 18;11(10). pii: E1590. doi: 10.3390/cancers11101590.

4.

Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation.

Chen HH, Stringer A, Eguale T, Rao GG, Ozawa S.

Am J Trop Med Hyg. 2019 Nov;101(5):1042-1053. doi: 10.4269/ajtmh.18-0930.

PMID:
31516111
5.

Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess.

Neill L, Edwards F, Collin SM, Harrington D, Wakerley D, Rao GG, McGregor AC.

BMC Infect Dis. 2019 Jun 3;19(1):490. doi: 10.1186/s12879-019-4127-8.

6.

Surgical Volume and Survival in Cervical Cancer: Bigger Is Better.

Rao GG.

Obstet Gynecol. 2019 Jun;133(6):1084-1085. doi: 10.1097/AOG.0000000000003293. No abstract available.

PMID:
31135721
7.

Surgical Volume and Survival in Cervical Cancer: Bigger Is Better.

Rao GG.

Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003293. [Epub ahead of print] No abstract available.

PMID:
31083134
8.

Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.

Lin YW, Abdul Rahim N, Zhao J, Han ML, Yu HH, Wickremasinghe H, Chen K, Wang J, Paterson DL, Zhu Y, Rao GG, Zhou QT, Forrest A, Velkov T, Li J.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02176-18. doi: 10.1128/AAC.02176-18. Print 2019 Apr.

9.

Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients.

Meaney CJ, Karas S, Robinson B, Gaesser J, Forrest A, Krzyzanski W, Panesar M, Rao GG.

J Clin Pharmacol. 2019 Mar;59(3):418-426. doi: 10.1002/jcph.1330. Epub 2018 Nov 9.

PMID:
30412269
10.

Comparison of the composition and in vitro activity of polymyxin B products.

Diep JK, Covelli J, Sharma R, Ruszaj DM, Kaye KS, Li J, Straubinger RM, Rao GG.

Int J Antimicrob Agents. 2018 Sep;52(3):365-371. doi: 10.1016/j.ijantimicag.2018.05.014. Epub 2018 May 25.

PMID:
29807163
11.

Cholera Epidemic - Lusaka, Zambia, October 2017-May 2018.

Sinyange N, Brunkard JM, Kapata N, Mazaba ML, Musonda KG, Hamoonga R, Kapina M, Kapaya F, Mutale L, Kateule E, Nanzaluka F, Zulu J, Musyani CL, Winstead AV, Davis WW, N'cho HS, Mulambya NL, Sakubita P, Chewe O, Nyimbili S, Onwuekwe EVC, Adrien N, Blackstock AJ, Brown TW, Derado G, Garrett N, Kim S, Hubbard S, Kahler AM, Malambo W, Mintz E, Murphy J, Narra R, Rao GG, Riggs MA, Weber N, Yard E, Zyambo KD, Bakyaita N, Monze N, Malama K, Mulwanda J, Mukonka VM.

MMWR Morb Mortal Wkly Rep. 2018 May 18;67(19):556-559. doi: 10.15585/mmwr.mm6719a5.

12.

Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia.

Diep JK, Russo TA, Rao GG.

CPT Pharmacometrics Syst Pharmacol. 2018 Aug;7(8):507-516. doi: 10.1002/psp4.12312. Epub 2018 Aug 24.

13.

Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm.

Lakota EA, Landersdorfer CB, Nation RL, Li J, Kaye KS, Rao GG, Forrest A.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00483-18. doi: 10.1128/AAC.00483-18. Print 2018 Jul.

14.

Unusual case of anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis and autoimmune polyglandular syndrome (APS).

Frunza-Stefan S, Whitlatch HB, Rao GG, Malek R.

BMJ Case Rep. 2018 May 2;2018. pii: bcr-2018-224821. doi: 10.1136/bcr-2018-224821.

PMID:
29724875
15.

Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.

Lin YW, Yu HH, Zhao J, Han ML, Zhu Y, Akter J, Wickremasinghe H, Walpola H, Wirth V, Rao GG, Forrest A, Velkov T, Li J.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00028-18. doi: 10.1128/AAC.00028-18. Print 2018 Jun.

16.

Incidence and risk factors for healthcare utilisation among patients discharged on outpatient parenteral antimicrobial therapy.

Jacobs DM, Leung WY, Essi D, Park W, Shaver A, Claus J, Ruh C, Rao GG.

Epidemiol Infect. 2018 Apr;146(6):782-787. doi: 10.1017/S0950268818000456. Epub 2018 Mar 14.

17.

Assessment and modelling of antibacterial combination regimens.

Rao GG, Li J, Garonzik SM, Nation RL, Forrest A.

Clin Microbiol Infect. 2018 Jul;24(7):689-696. doi: 10.1016/j.cmi.2017.12.004. Epub 2017 Dec 18. Review.

18.

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).

Woodford N, Xu-McCrae L, Mushtaq S, Wu HHT, Ellington MJ, Lancaster O, Davies F, Donaldson H, Rao GG, Verma A, Wareham DW, Ciesielczuk H, Stone GG, Irani PM, Bracher S, Hawkey PM.

J Antimicrob Chemother. 2018 Mar 1;73(3):698-702. doi: 10.1093/jac/dkx471.

PMID:
29253163
19.

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.

Diep JK, Sharma R, Ellis-Grosse EJ, Abboud CS, Rao GG.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01815-17. doi: 10.1128/AAC.01815-17. Print 2018 Feb.

20.

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis.

Abboud CS, Rao GG, Souza EE, Zavascki AP, Kiffer C.

Braz J Infect Dis. 2018 Jan - Feb;22(1):51-54. doi: 10.1016/j.bjid.2017.10.006. Epub 2017 Nov 26.

21.

Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.

Jacobs DM, Safir MC, Huang D, Minhaj F, Parker A, Rao GG.

Ann Clin Microbiol Antimicrob. 2017 Nov 25;16(1):76. doi: 10.1186/s12941-017-0249-2. Review.

22.

Barriers to Timely Completion of Radiation Therapy in Patients with Cervical Cancer in an Urban Tertiary Care Center.

Cohen J, Harper A, Nichols EM, Rao GG, Mohindra P, Roque DM.

Cureus. 2017 Sep 12;9(9):e1681. doi: 10.7759/cureus.1681.

23.

Point prevalence & risk factor assessment for hospital-acquired infections in a tertiary care hospital in Pune, India.

Nair V, Sahni AK, Sharma D, Grover N, Shankar S, Chakravarty A, Patrikar S, Methe K, Jaiswal SS, Dalal SS, Kapur A, Verma R, Prakash J, Gupta A, Bhansali A, Batura D, Rao GG, Joshi DP, Chopra BK.

Indian J Med Res. 2017 Jun;145(6):824-832. doi: 10.4103/ijmr.IJMR_1167_15.

24.

The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices.

Covelli J, Ruszaj D, Straubinger R, Li J, Rao GG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 15;1065-1066:112-118. doi: 10.1016/j.jchromb.2017.09.031. Epub 2017 Sep 21.

PMID:
28961485
25.

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

Gonzalez D, Rao GG, Bailey SC, Brouwer KLR, Cao Y, Crona DJ, Kashuba ADM, Lee CR, Morbitzer K, Patterson JH, Wiltshire T, Easter J, Savage SW, Powell JR.

Clin Transl Sci. 2017 Nov;10(6):443-454. doi: 10.1111/cts.12490. Epub 2017 Aug 10. Review. No abstract available.

26.

Determination and Validation of a Lower Cut Off Value of Cerebrospinal Fluid Adenosine Deaminase (CSF-ADA) Activity in Diagnosis of Tuberculous Meningitis.

Raviraj, Henry RA, Rao GG.

J Clin Diagn Res. 2017 Apr;11(4):OC22-OC24. doi: 10.7860/JCDR/2017/25823.9625. Epub 2017 Apr 1.

27.

In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae.

Huang D, Yu B, Diep JK, Sharma R, Dudley M, Monteiro J, Kaye KS, Pogue JM, Abboud CS, Rao GG.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00073-17. doi: 10.1128/AAC.00073-17. Print 2017 Jul.

28.

Critical Need for Clarity in Polymyxin B Dosing.

Onufrak NJ, Rao GG, Forrest A, Pogue JM, Scheetz MH, Nation RL, Li J, Kaye KS.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00208-17. doi: 10.1128/AAC.00208-17. Print 2017 May. No abstract available.

29.

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B.

Krzyzanski W, Rao GG.

PLoS One. 2017 Mar 23;12(3):e0171834. doi: 10.1371/journal.pone.0171834. eCollection 2017.

30.

Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.

Sharma R, Patel S, Abboud C, Diep J, Ly NS, Pogue JM, Kaye KS, Li J, Rao GG.

Int J Antimicrob Agents. 2017 Feb;49(2):224-232. doi: 10.1016/j.ijantimicag.2016.10.025. Epub 2016 Dec 23.

31.

Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.

Diep JK, Jacobs DM, Sharma R, Covelli J, Bowers DR, Russo TA, Rao GG.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02121-16. doi: 10.1128/AAC.02121-16. Print 2017 Feb.

32.

ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer.

Wahl AO, Gaffney DK, Jhingran A, Yashar CM, Biagioli M, Elshaikh MA, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Williams NL, Small W Jr.

Oncology (Williston Park). 2016 Sep 15;30(9):816-22. Review.

33.

Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.

Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT.

J Antimicrob Chemother. 2016 Nov;71(11):3148-3156. Epub 2016 Aug 3.

34.

Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.

Rao GG, Ly NS, Diep J, Forrest A, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT.

Int J Antimicrob Agents. 2016 Sep;48(3):331-6. doi: 10.1016/j.ijantimicag.2016.06.006. Epub 2016 Jul 12.

35.

ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer.

Elshaikh MA, Vance S, Gaffney DK, Biagioli M, Jhingran A, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr; Expert Panel on Radiation Oncology–Gynecology:.

Am J Clin Oncol. 2016 Oct;39(5):507-15. doi: 10.1097/COC.0000000000000318.

PMID:
27400117
36.

Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient.

Jacobs DM, DiTursi S, Ruh C, Sharma R, Claus J, Banjade R, Rao GG.

Int J Antimicrob Agents. 2016 Aug;48(2):225-7. doi: 10.1016/j.ijantimicag.2016.06.002. Epub 2016 Jun 23. No abstract available.

PMID:
27396948
37.

Antibiotics for tonsillitis: should the emergency department emulate general practice?

Kanji K, Saatci D, Rao GG, Khanna P, Bassett P, Williams B, Khan M.

J Clin Pathol. 2016 Sep;69(9):834-6. doi: 10.1136/jclinpath-2016-203808. Epub 2016 Jun 29.

PMID:
27358410
38.

Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.

Abboud CS, Monteiro J, Stryjewski ME, Zandonadi EC, Barbosa V, Dantas D, Sousa EE, Fonseca MJ, Jacobs DM, Pignatari AC, Kiffer C, Rao GG.

Int J Antimicrob Agents. 2016 May;47(5):386-90. doi: 10.1016/j.ijantimicag.2016.02.015. Epub 2016 Apr 6.

PMID:
27155944
39.

Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.

Tsuji BT, Landersdorfer CB, Lenhard JR, Cheah SE, Thamlikitkul V, Rao GG, Holden PN, Forrest A, Bulitta JB, Nation RL, Li J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3913-20. doi: 10.1128/AAC.02831-15. Print 2016 Jul.

40.

Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.

Ly NS, Bulman ZP, Bulitta JB, Baron C, Rao GG, Holden PN, Li J, Sutton MD, Tsuji BT.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2870-80. doi: 10.1128/AAC.02377-15. Print 2016 May.

41.

ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.

Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr.

Oncology (Williston Park). 2015 Nov;29(11):867-72, 874-5.

42.

Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.

Kaucher KA, Acquisto NM, Rao GG, Kaufman DC, Huntress JD, Forrest A, Haas CE.

Pharmacotherapy. 2015 May;35(5):482-8. doi: 10.1002/phar.1589.

PMID:
26011141
43.

Diagnosis and management of persistent pulmonary hypertension of the newborn.

Bendapudi P, Rao GG, Greenough A.

Paediatr Respir Rev. 2015 Jun;16(3):157-61. doi: 10.1016/j.prrv.2015.02.001. Epub 2015 Feb 10. Review.

PMID:
25765845
44.

Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.

Ly NS, Bulitta JB, Rao GG, Landersdorfer CB, Holden PN, Forrest A, Bergen PJ, Nation RL, Li J, Tsuji BT.

J Antimicrob Chemother. 2015 May;70(5):1434-42. doi: 10.1093/jac/dku567. Epub 2015 Feb 23.

45.

ACR appropriateness Criteria® advanced stage endometrial cancer.

Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK; Expert Panel on Radiation Oncology-Gynecology:.

Am J Clin Oncol. 2014 Aug;37(4):391-6. doi: 10.1097/COC.0000000000000098.

PMID:
24977691
46.

Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, Rao GG, Dash A, Park S, Patel N, Woo J, McDonald M, Nseyo U, Banapour P, Unterberg S, Ahlering TE, Van Poppel H, Sakamoto K, Fierer J, Black PC.

J Urol. 2014 Dec;192(6):1673-8. doi: 10.1016/j.juro.2014.06.005. Epub 2014 Jun 10.

PMID:
24928266
47.

Acr appropriateness Criteria management of vaginal cancer.

Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK.

Oncology (Williston Park). 2013 Nov;27(11):1166-73. Review.

48.

New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease.

Rao GG, Ly NS, Haas CE, Garonzik S, Forrest A, Bulitta JB, Kelchlin PA, Holden PN, Nation RL, Li J, Tsuji BT.

Antimicrob Agents Chemother. 2014;58(3):1381-8. doi: 10.1128/AAC.00327-13. Epub 2013 Dec 16.

49.

ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.

Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Am J Clin Oncol. 2013 Aug;36(4):415-22. doi: 10.1097/COC.0b013e318295af1d. Review.

PMID:
23872794
50.

Neonatal Granulicatella elegans bacteremia, London, UK.

Quartermain L, Tailor H, Njenga S, Bhattacharjee P, Rao GG.

Emerg Infect Dis. 2013 Jul;19(7):1165-6. doi: 10.3201/eid.1907.130009. No abstract available.

Supplemental Content

Support Center